191. Werner syndrome
3 clinical trials,   4 drugs   (DrugBank: 3 drugs),   1 drug target gene,   5 drug target pathways

Searched query = "Werner syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs031190141
27/11/201927/11/2019Cross-over trial to verify safety and effectiveness of nicotinamide riboside and pterostilbene for patients with Werner syndromeProspective, single-center, cross-over trial to verify safety and effectiveness of nicotinamide riboside and pterostilbene for patients with Werner syndrome - EMPOWER Werner syndrome
Werner syndrome;C16.320.925 / C18.452.284.960
Subjects ingest oral capsules of NRPT (nicotinamide riboside and pterostilbene) once daily (total daily dose: nicotinamide riboside 500 mg and pterostilbene 100mg) and placebo capsules for 6 months each in a randomly determined order.Yokote KoutaroNULLRecruiting>= 20age oldNot applicableBoth30Japan